Veracyte Inc (VCYT)
Smart-money score is below the middle — business numbers score is on the high side.
VCYT scores higher than 60% of the 1,101 tickers we compare it with (Health Care).
As of 9 October 2026, Veracyte Inc (VCYT) scores 46 out of 100 on the Market Census six-factor composite, which puts it at the Average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.
Updated · scores usually change about once a day
Key statistics
Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.
- Relative volume
- 0.69× 30-day average
- 52-week range
- 29.45 – 60.91
- Market cap
- $3.20B
- Earnings date
- 2 Nov 2026
- Volume
- 966,542
- Avg. volume (30d)
- 1,396,504
- Open
- 43.70
- Previous close
- 43.60
- Day's range (regular session)
- 43.50 – 46.17
The last trade can be an extended-hours trade, so it can sit outside the regular-session range.
Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.
- Beta
- 1.99
- P/E (TTM)
- 30.31
- EPS (TTM)
- 1.40
Score breakdown · six named factors
Each bar is one part of the score, from 0 to 100. Read what the score means.
Premium data held for VCYT
- 15 SEC Form 4 insider transactions in the last 90 daysPremium
Counts of rows Market Census holds for VCYT. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans
What the score says about VCYT right now
Veracyte Inc (VCYT) currently scores 46/100 on the Market Census six-factor composite, at the Average score level. VCYT is +3.74% on the day and -0.90% over five sessions as of the most recent tick. Average sits in the middle. The good and the bad in VCYT's data roughly balance out right now. VCYT's strongest factor is company finances at 65/100 — a strong read on the company's own reported numbers. A high reading doesn't promise a near-term move. The weakest factor is insider trades at 10/100 — a well below average read on insider buying and selling. Insider filings for VCYT lean toward selling; on a thinly filed name a few filings can set this reading.
Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.
See VCYT in the scanner
This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).
Recent VCYT news
Latest headlines that name Veracyte, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).
- Veracyte (VCYT) Stock Still Looks Cheap As Its 107% Run ContinuesYahoo
- Veracyte (VCYT) Is Down 9.0% After New Level 1B1 Decipher Prostate Data at ASTRO 2026Yahoo
- Could Veracyte (VCYT) Change Prostate Cancer Care With New Phase III Data?Yahoo
- Veracyte To Present New Findings From Retrospective Ancillary Analysis Of Randomized Phase III NRG/RTOG 0815 Trial At 2026 ASTRO Annual MeetingBenzinga
- Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026GlobeNewswire Inc.
We hide 1 more that told readers to buy or sell, or gave a price target.
Saved snapshot; the news and prices on this page can be an hour old or more.
Similar setups in Health Care right now
Six health care tickers whose composite scores are closest to VCYT’s 46, all within 1 point.
Sorted by closeness to VCYT’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →
Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.